Home fda
 

Keywords :   


Tag: fda

ANDAs: FDA Guidance on Stability Testing of Generic Products

2014-12-19 11:57:05| drugdiscoveryonline Home Page

Date: Thursday, February 12, 2015 Time: 1pm - 2:30pm EST Duration: 90 Minutes - Online $299 - Introductory Rate

Tags: products testing guidance generic

 

Taiwan FDA finds banned dye in dried tofu

2014-12-17 01:00:00| Food Processing Technology

Taiwans Food and Drug Administration (FDA) has found traces of banned industrial dyes in several dried tofu products, months after the country's cooking oil scandal.

Tags: taiwan finds dried banned

 
 

FDA Approves Merck's HPV Vaccine, GARDASIL9, to Prevent Cancers and Other Diseases Caused by Nine HPV types Including Types that Cause About 90% of Cervical Cancer Cases

2014-12-11 23:30:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. GARDASIL 9 includes the greatest number of HPV types in any available HPV vaccine KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Deb Wambold, 215-652-2913orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: of that including types

 

FDA Issues Warning Letter To Cell Vitals

2014-12-04 06:12:00| Happi Breaking News

Contends website is promoting products as drugs under The Cosmetic Act.

Tags: issues cell letter warning

 

U.S. FDA approves Amgen leukemia drug ahead of schedule

2014-12-04 00:02:10| Biotech - Topix.net

U.S. health regulators on Wednesday approved an Amgen Inc drug that helps the immune system fight a rare type of leukemia, more than five months ahead of the expected decision date. The drug, blinatumomab, which will be sold under the brand name Blincyto, was approved to treat a form of acute lymphoblastic leukemia for which there are currently virtually no treatment options.

Tags: drug schedule ahead fda

 

Sites : [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] next »